BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 8663298)

  • 1. Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3.
    Fowlkes JL; Serra DM
    J Biol Chem; 1996 Jun; 271(25):14676-9. PubMed ID: 8663298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.
    Coleman KL; Chiaramonti M; Haddad B; Ranzenberger R; Henning H; Al Khashali H; Ray R; Darweesh B; Guthrie J; Heyl D; Evans HG
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like Growth Factor Binding Protein 3 Increases Mouse Preimplantation Embryo Cleavage Rate by Activation of IGF1R and EGFR Independent of IGF1 Signalling.
    Green CJ; Span M; Rayhanna MH; Perera M; Day ML
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing Roles of IGFBP-3 and Heparanase in Regulating A549 Lung Cancer Cell Survival.
    Al Khashali H; Wareham J; Ray R; Haddad B; Coleman KL; Ranzenberger R; McCombs P; Guthrie J; Heyl D; Evans HG
    Cells; 2022 Nov; 11(22):. PubMed ID: 36428962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colostrogenesis: Role and Mechanism of the Bovine Fc Receptor of the Neonate (FcRn).
    Baumrucker CR; Macrina AL; Bruckmaier RM
    J Mammary Gland Biol Neoplasia; 2021 Dec; 26(4):419-453. PubMed ID: 35080749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered IGF-I activity and accelerated bone elongation in growth plates precede excess weight gain in a mouse model of juvenile obesity.
    Machnicki AL; White CA; Meadows CA; McCloud D; Evans S; Thomas D; Hurley JD; Crow D; Chirchir H; Serrat MA
    J Appl Physiol (1985); 2022 Feb; 132(2):511-526. PubMed ID: 34989650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical determinants of the IGFBP-3-hyaluronan interaction.
    Dorandish S; Devos J; Clegg B; Price D; Muterspaugh R; Guthrie J; Heyl DL; Evans HG
    FEBS Open Bio; 2020 Aug; 10(8):1668-1684. PubMed ID: 32592613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell.
    Varma Shrivastav S; Bhardwaj A; Pathak KA; Shrivastav A
    Front Cell Dev Biol; 2020; 8():286. PubMed ID: 32478064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer.
    Cai Q; Dozmorov M; Oh Y
    Cells; 2020 May; 9(5):. PubMed ID: 32443727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP-3 Blocks Hyaluronan-CD44 Signaling, Leading to Increased Acetylcholinesterase Levels in A549 Cell Media and Apoptosis in a p53-Dependent Manner.
    Price D; Muterspaugh R; Clegg B; Williams A; Stephens A; Guthrie J; Heyl D; Evans HG
    Sci Rep; 2020 Mar; 10(1):5083. PubMed ID: 32193421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP-2 Signaling in the Brain: From Brain Development to Higher Order Brain Functions.
    Khan S
    Front Endocrinol (Lausanne); 2019; 10():822. PubMed ID: 31824433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of full-length human insulin-like growth factor binding protein 3 (IGFBP3) in the Escherichia coli.
    Khodadadi E; Panjepour M; Abbasian M; Broujeni ZK; Mofid MR
    Adv Biomed Res; 2015; 4():66. PubMed ID: 25878991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.
    Lee H; Kim SR; Oh Y; Cho SH; Schleimer RP; Lee YC
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):667-77. PubMed ID: 24219511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core functional sequence of C-terminal GAG-binding domain directs cellular uptake of IGFBP-3-derived peptides.
    Liu D; Zhang X; Gao J; Palombo M; Gao D; Chen P; Sinko PJ
    Protein Pept Lett; 2014; 21(2):124-31. PubMed ID: 24059751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity.
    Moreno MJ; Ball M; Rukhlova M; Slinn J; L'abbe D; Iqbal U; Monette R; Hagedorn M; O'Connor-McCourt MD; Durocher Y; Stanimirovic DB
    Neoplasia; 2013 May; 15(5):554-67. PubMed ID: 23633927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1.
    Jacobo SM; Deangelis MM; Kim IK; Kazlauskas A
    Mol Cell Biol; 2013 May; 33(10):1976-90. PubMed ID: 23478260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin Modulates Insulin-like Growth Factor Axis: Implications for Prevention and Therapy of Prostate Cancer.
    Babcook MA; Gupta S
    Curr Drug Targets; 2012 Nov; ():. PubMed ID: 23140291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding proteins: a structural perspective.
    Forbes BE; McCarthy P; Norton RS
    Front Endocrinol (Lausanne); 2012; 3():38. PubMed ID: 22654863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?
    Smith TJ
    Pharmacol Rev; 2010 Jun; 62(2):199-236. PubMed ID: 20392809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling insulin-like growth factor binding protein-3 actions in human disease.
    Jogie-Brahim S; Feldman D; Oh Y
    Endocr Rev; 2009 Aug; 30(5):417-37. PubMed ID: 19477944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.